Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol-Reference-Cited by-同舟云学术

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol

Published:2021 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Hirano Tsutomu¹,Kodera Rieko¹,Hirashima Takeshi¹,Suzuki Natsuko¹,Aoki Ema¹,Hosoya Mitsuru¹,Oshima Taito¹,Hayashi Toshiyuki²,Koba Shinji³,Ohta Motoko⁴,Satoh Noriyuki⁴,Ito Yasuki⁴

Affiliation:

1. Diabetes Center, Ebina General Hospital

2. Yurakubashi Clinic

3. Division of Comprehensive Internal Medicine, Department of Perioperative Medicine, Showa University School of Dentistry

4. R&D Department, Denka Co., Ltd.

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_62789/_pdf

Reference28 articles.

1. 1) Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N: Japan Diabetes Complications Study Group, Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab, 2011; 96: 3448-3456

2. 2) Taskinen MR: Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia, 2003; 46: 733-749

3. 3) Verges B: Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia, 2015; 58: 886-899

4. 4) Stahlman M, Pham HT, Adiels M, Mitchell TW, Blanksby SJ, Fagerberg B, K Ekroos K, Borén J: Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes. Diabetologia, 2012; 55: 1156-1166

5. 5) Berneis KK, Krauss RM: Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res, 2002; 43: 1363-1379

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory markers of metabolic syndrome;Exploration of Cardiology;2024-06-24

2. Research Progress of Small Dense Low-Density Lipoprotein and Cardiovascular Disease;Advances in Clinical Medicine;2024

3. Low-density lipoprotein triglycerides: A marker for metabolic diseases;Annales de Biologie Clinique;2023-11

4. Small Dense Low-Density Lipoprotein Cholesterol Levels in Breakfast Skippers and Staple Foods Skippers;Journal of Atherosclerosis and Thrombosis;2023-10-01

5. Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy;Journal of Diabetes Investigation;2023-08-30